Dr. Reddys Laboratories Stock Updates and Market Analysis in September 2026
Dr. Reddys Laboratories' stock updates show last traded prices around 1198 to 1208 INR, with market capitalization near 100,500 to 100,900 crore INR and volumes ranging from approximately 122,000 to 283,000 shares. The price-to-earnings ratio is about 31.1 to 31.3, and earnings per share stand at 38.6. These live updates include both fundamental and technical analyses, offering investors timely insights to guide their decisions as of late September 2026.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 29/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 24 Sept, 05:29 am. Other outlets followed.
- 1